• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CISNE:一种准确描述联合治疗中剂量-效应和协同作用的方法。

CISNE: An accurate description of dose-effect and synergism in combination therapies.

机构信息

Departamento de Física, Universidad de Oviedo, Oviedo, E-33007, Spain.

Oncology University Institute of the Principality of Asturias (IUOPA), Oviedo, 33006, Spain.

出版信息

Sci Rep. 2018 Mar 21;8(1):4964. doi: 10.1038/s41598-018-23321-6.

DOI:10.1038/s41598-018-23321-6
PMID:29563526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5862869/
Abstract

The precise determination of dose-effect curves and the combination effect of drugs is of crucial importance in the development of new therapies for the most dreadful diseases. We have found that the current implementations of the theory of Chou et al. are not accurate enough in some circumstances and might lead to erroneous predictions of synergistic or antagonistic behaviour. We have identified the source of inaccuracies and fixed it thereby improving the accuracy of those methods. Here we explain the main features of our approach and demonstrate its higher accuracy as compared to the standard methods. Therefore, this new implementation might have a huge impact in the reliability of future research on new Combination Therapies.

摘要

精确确定剂量-效应曲线和药物的组合效应对于开发最可怕疾病的新疗法至关重要。我们发现,Chou 等人的理论目前的实现方式在某些情况下不够准确,可能导致对协同或拮抗行为的错误预测。我们已经确定了不准确的来源,并对其进行了修复,从而提高了这些方法的准确性。在这里,我们解释了我们方法的主要特点,并证明了它与标准方法相比具有更高的准确性。因此,这种新的实现方式可能会对未来新组合疗法研究的可靠性产生巨大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/571fdeafcba1/41598_2018_23321_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/dce761a2d1da/41598_2018_23321_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/6bc2754abcb6/41598_2018_23321_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/8644043b96fe/41598_2018_23321_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/e9f16e7e8b08/41598_2018_23321_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/0a140cc1f87d/41598_2018_23321_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/571fdeafcba1/41598_2018_23321_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/dce761a2d1da/41598_2018_23321_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/6bc2754abcb6/41598_2018_23321_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/8644043b96fe/41598_2018_23321_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/e9f16e7e8b08/41598_2018_23321_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/0a140cc1f87d/41598_2018_23321_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efb/5862869/571fdeafcba1/41598_2018_23321_Fig6_HTML.jpg

相似文献

1
CISNE: An accurate description of dose-effect and synergism in combination therapies.CISNE:一种准确描述联合治疗中剂量-效应和协同作用的方法。
Sci Rep. 2018 Mar 21;8(1):4964. doi: 10.1038/s41598-018-23321-6.
2
Interaction index and different methods for determining drug interaction in combination therapy.联合治疗中相互作用指数及确定药物相互作用的不同方法。
J Biopharm Stat. 2007;17(3):461-80. doi: 10.1080/10543400701199593.
3
bayesynergy: flexible Bayesian modelling of synergistic interaction effects in in vitro drug combination experiments.贝叶斯协同:体外药物组合实验中协同相互作用效应的灵活贝叶斯建模。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab251.
4
Rational approach to the clinical protocol design for drug combinations: a review.药物联合临床方案设计的合理方法:综述
Acta Paediatr Taiwan. 2000 Nov-Dec;41(6):294-302.
5
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application.药物-药物相互作用和协同作用:从药理学模型到临床应用。
Pharmacol Rev. 2024 Oct 16;76(6):1159-1220. doi: 10.1124/pharmrev.124.000951.
6
Advances and limitations in the evaluation of analgesic combination therapy.镇痛联合治疗评估的进展与局限
Neurology. 2005 Dec 29;65(12 Suppl 4):S3-6. doi: 10.1212/wnl.65.12_suppl_4.s3.
7
Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.使用基于CalcuSyn的相互作用计算方法研究盐酸二氢吐根碱水合物的抗疟药物相互作用。
PLoS One. 2017 Mar 3;12(3):e0173303. doi: 10.1371/journal.pone.0173303. eCollection 2017.
8
A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scores.一种使用蛋白质-药物对接分数预测细胞毒性混合物协同作用/拮抗作用的分类模型。
BMC Pharmacol. 2008 Jul 29;8:13. doi: 10.1186/1471-2210-8-13.
9
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.药物联合研究中协同作用和拮抗作用的理论基础、实验设计及计算机模拟
Pharmacol Rev. 2006 Sep;58(3):621-81. doi: 10.1124/pr.58.3.10.
10
Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment.化学生物基因组学模型确定了对病原体微环境具有稳健协同作用的药物组合。
PLoS Comput Biol. 2018 Dec 31;14(12):e1006677. doi: 10.1371/journal.pcbi.1006677. eCollection 2018 Dec.

引用本文的文献

1
Advantages and Challenges of Using Antimicrobial Peptides in Synergism with Antibiotics for Treating Multidrug-Resistant Bacteria.抗菌肽与抗生素协同用于治疗多重耐药菌的优势与挑战
ACS Infect Dis. 2025 Feb 14;11(2):323-334. doi: 10.1021/acsinfecdis.4c00702. Epub 2025 Jan 24.
2
N-of-1 medicine.N-of-1 医学。
Singapore Med J. 2024 Mar 1;65(3):167-175. doi: 10.4103/singaporemedj.SMJ-2023-243. Epub 2024 Mar 26.
3
Antimicrobial Properties of New Polyamines Conjugated with Oxygen-Containing Aromatic Functional Groups.

本文引用的文献

1
Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses.吉非替尼联合化疗对比化疗用于一线吉非替尼耐药的表皮生长因子受体突变阳性非小细胞肺癌(IMPRESS):总生存和生物标志物分析。
J Clin Oncol. 2017 Dec 20;35(36):4027-4034. doi: 10.1200/JCO.2017.73.9250. Epub 2017 Oct 2.
2
A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer.培美曲塞联合表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非鳞状非小细胞肺癌的研究进展。
Clin Lung Cancer. 2018 Jan;19(1):27-34. doi: 10.1016/j.cllc.2017.06.013. Epub 2017 Jul 6.
3
新型含氧化芳香族官能团多胺的抗菌性能。
Molecules. 2023 Nov 20;28(22):7678. doi: 10.3390/molecules28227678.
4
Combinatorial efficacy of Manuka honey and antibiotics in the control of staphylococci and their small colony variants.麦卢卡蜂蜜与抗生素联用在控制葡萄球菌及其小菌落变异体中的协同功效。
Front Cell Infect Microbiol. 2023 Oct 19;13:1219984. doi: 10.3389/fcimb.2023.1219984. eCollection 2023.
5
Estrogen receptor α interaction of zearalenone and its phase I metabolite α-zearalenol in combination with soy isoflavones in hERα-HeLa-9903 cells.玉米赤霉烯酮及其代谢产物α-玉米赤霉醇与大豆异黄酮在 hERα-HeLa-9903 细胞中的雌激素受体 α 相互作用。
Mycotoxin Res. 2024 Feb;40(1):97-109. doi: 10.1007/s12550-023-00506-1. Epub 2023 Oct 17.
6
Increased radical scavenging activity of thymoquinone and l-ascorbic acid dual encapsulated in palmitoyl-chitosan nanoparticles in a human normal lung fibroblast, MRC-5 due to synergistic antioxidative effects.由于协同抗氧化作用,包封在棕榈酰壳聚糖纳米颗粒中的百里醌和L-抗坏血酸在人正常肺成纤维细胞MRC-5中具有增强的自由基清除活性。
RSC Adv. 2023 Sep 20;13(40):27965-27983. doi: 10.1039/d3ra04326f. eCollection 2023 Sep 18.
7
A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer.一种具有四种作用机制的环丙沙星衍生物克服了 p53 突变和 MDR1 基因表达的 II 型人子宫内膜癌对紫杉醇的耐药性。
Biomaterials. 2023 May;296:122093. doi: 10.1016/j.biomaterials.2023.122093. Epub 2023 Mar 17.
8
Modulatory effects of phytol on the antiemetic property of domperidone, possibly through the D receptor interaction pathway: in vivo and in silico studies.叶绿醇对多潘立酮止吐特性的调节作用,可能通过D受体相互作用途径:体内和计算机模拟研究
3 Biotech. 2023 Apr;13(4):116. doi: 10.1007/s13205-023-03520-3. Epub 2023 Mar 11.
9
Advances and perspectives for antimicrobial peptide and combinatory therapies.抗菌肽及联合疗法的进展与展望
Front Bioeng Biotechnol. 2022 Dec 12;10:1051456. doi: 10.3389/fbioe.2022.1051456. eCollection 2022.
10
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort.伴有猝倒的一大群患者的临床特征:来自意大利 PASS Wakix®队列的一项横断面研究。
Neurol Sci. 2022 Sep;43(9):5563-5574. doi: 10.1007/s10072-022-06210-9. Epub 2022 Jun 25.
Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells.索拉非尼与大豆黄素的新型组合协同增强对肝癌细胞的抗增殖和促凋亡作用。
Sci Rep. 2016 Jul 29;6:30717. doi: 10.1038/srep30717.
4
NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning.NLLSS:基于半监督学习预测协同药物组合
PLoS Comput Biol. 2016 Jul 14;12(7):e1004975. doi: 10.1371/journal.pcbi.1004975. eCollection 2016 Jul.
5
Drug Combinations: Tests and Analysis with Isoboles.药物组合:用等效线图进行测试与分析
Curr Protoc Pharmacol. 2016 Mar 18;72:9.19.1-9.19.19. doi: 10.1002/0471141755.ph0919s72.
6
Systematic synergy modeling: understanding drug synergy from a systems biology perspective.系统协同建模:从系统生物学角度理解药物协同作用。
BMC Syst Biol. 2015 Sep 16;9:56. doi: 10.1186/s12918-015-0202-y.
7
Drug-target interaction prediction: databases, web servers and computational models.药物-靶点相互作用预测:数据库、网络服务器和计算模型。
Brief Bioinform. 2016 Jul;17(4):696-712. doi: 10.1093/bib/bbv066. Epub 2015 Aug 17.
8
Analysis of drug combinations: current methodological landscape.药物联合分析:当前方法学全景。
Pharmacol Res Perspect. 2015 Jun;3(3):e00149. doi: 10.1002/prp2.149. Epub 2015 May 20.
9
Novel HIV-1 treatment Stribild™ gains regulatory approval.新型HIV-1治疗药物Stribild™获得监管批准。
Expert Rev Clin Pharmacol. 2012 Nov;5(6):613. doi: 10.1586/ecp.12.67.
10
Quantitative methods for assessing drug synergism.评估药物协同作用的定量方法。
Genes Cancer. 2011 Nov;2(11):1003-8. doi: 10.1177/1947601912440575.